These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10772546)

  • 1. Humoral immune responses against Plasmodium vivax MSP1 in humans living in a malaria endemic area in Flores, Indonesia.
    Ak M; Jones TR; Charoenvit Y; Kumar S; Kaslow DC; Maris D; Marwoto H; Masbar S; Hoffman SL
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):685-91. PubMed ID: 10772546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey.
    Zeyrek FY; Babaoglu A; Demirel S; Erdogan DD; Ak M; Korkmaz M; Coban C
    Am J Trop Med Hyg; 2008 May; 78(5):729-32. PubMed ID: 18458304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
    Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
    Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium vivax: immune responses in a cross-section of the population in the Delhi area of India.
    Ray P; Ansari MA; Sharma YD
    Am J Trop Med Hyg; 1994 Oct; 51(4):436-43. PubMed ID: 7943570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
    Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
    Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity.
    Morais CG; Soares IS; Carvalho LH; Fontes CJ; Krettli AU; Braga EM
    Am J Trop Med Hyg; 2006 Oct; 75(4):582-7. PubMed ID: 17038677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
    Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey.
    Zeyrek FY; Kurcer MA; Zeyrek D; Simsek Z
    Parasite Immunol; 2006 May; 28(5):201-7. PubMed ID: 16629705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of two species of malaria, Plasmodium falciparum and Plasmodium vivax, on Lombok Island, Indonesia.
    Nagao Y; Dachlan YP; Soedarto ; Hidajati S; Yotopranoto S; Kusmartisnawati ; Subekti S; Ideham B; Tsuda Y; Kawabata M; Takagi M; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):495-500. PubMed ID: 15115118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally acquired immunity and reduced susceptibility to falciparum malaria in two subpopulations of endemic eastern India.
    Biswas S; Seth RK; Tyagi PK; Sharma SK; Dash AP
    Scand J Immunol; 2008 Feb; 67(2):177-84. PubMed ID: 18086262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in eastern Indonesia.
    Sutanto I; Suprijanto S; Nurhayati ; Manoempil P; Baird JK
    Am J Trop Med Hyg; 2009 Aug; 81(2):338-42. PubMed ID: 19635895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endemic coastal malaria in the Thousand Islands District, near Jakarta, Indonesia.
    Maguire JD; Tuti S; Sismadi P; Wiady I; Basri H; Krisin ; Masbar S; Projodipuro P; Elyazar IR; Corwin AL; Bangs MJ
    Trop Med Int Health; 2005 May; 10(5):489-96. PubMed ID: 15860097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein 1 in a transmigrant population requires multiple infections.
    Murhandarwati EE; Black CG; Wang L; Weisman S; Koning-Ward TF; Baird JK; Tjitra E; Richie TL; Crabb BS; Coppel RL
    J Infect Dis; 2008 Oct; 198(8):1212-8. PubMed ID: 18717639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria endemicity in an Orang Asli community in Pahang, Malaysia.
    Gurpreet K
    Trop Biomed; 2009 Apr; 26(1):57-66. PubMed ID: 19696728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired immune response to defined Plasmodium vivax antigens in individuals residing in northern India.
    Seth RK; Bhat AA; Rao DN; Biswas S
    Microbes Infect; 2010 Mar; 12(3):199-206. PubMed ID: 20034587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
    Carter R; David P; Mendis K
    Parassitologia; 1993 Jul; 35 Suppl():17-8. PubMed ID: 8233604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria epidemiology in low-endemicity areas of the Atlantic Forest in the Vale do Ribeira, São Paulo, Brazil.
    Curado I; Dos Santos Malafronte R; de Castro Duarte AM; Kirchgatter K; Branquinho MS; Bianchi Galati EA
    Acta Trop; 2006 Nov; 100(1-2):54-62. PubMed ID: 17126279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa.
    Culleton R; Ndounga M; Zeyrek FY; Coban C; Casimiro PN; Takeo S; Tsuboi T; Yadava A; Carter R; Tanabe K
    J Infect Dis; 2009 Nov; 200(9):1465-9. PubMed ID: 19803728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.
    Versiani FG; Almeida ME; Melo GC; Versiani FO; Orlandi PP; Mariúba LA; Soares LA; Souza LP; da Silva Balieiro AA; Monteiro WM; Costa FT; del Portillo HA; Lacerda MV; Nogueira PA
    Malar J; 2013 Aug; 12():294. PubMed ID: 23977965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.